Bank Of New York Mellon Corp Vista Gen Therapeutics, Inc. Transaction History

Bank Of New York Mellon Corp

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$0.09 - $4.8 $52,117 - $2.78 Million	579,081 New	579,081 $57,000
Q3 2022 Nov 14, 2022	SELL	$0.14 - $4.8 $18,908 - $648,283	-135,059 Reduced 18.91%	579,081 $88,000
Q2 2022 Aug 15, 2022	SELL	$0.88 - $1.73 $48,143 - $94,644	-54,708 Reduced 7.12%	714,140 $628,000
Q1 2022 May 11, 2022	SELL	$1.14 - $2.09 $50,552 - $92,678	-44,344 Reduced 5.45%	768,848 $954,000
Q4 2021 Feb 11, 2022	BUY	$1.67 - $2.76 $367,086 - $606,681	219,812 Added 37.04%	813,192 $1.59 Million
Q3 2021 Nov 12, 2021	BUY	$2.62 - $3.45 $326,045 - $429,335	124,445 Added 26.54%	593,380 $1.63 Million
Q2 2021 Aug 11, 2021	BUY	$1.96 - $3.15 $795,969 - $1.28 Million	406,107 Added 646.38%	468,935 $0
Q1 2021 May 13, 2021	BUY	$1.89 - $2.96 $9,718 - $15,220	5,142 Added 8.91%	62,828 $0
Q4 2020 Feb 09, 2021	BUY	$0.65 - $1.94 $37,495 - $111,910	57,686 New	57,686 $0

2.7M

Ticker VTGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 206,836,000
Market Cap $610M
Description
VistaGen Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing and commercializing various medicines with the potential to care for anxiety, depression, and other disorders of the central nervous system (CNS). The company's CNS pipeline includes PH94B, a rapid-onset neuroactive nasal spray, which is in Phase III d...

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

Stay updated on Bank Of New York Mellon Corp with notifications on news.